Recipe for DisasterRecently both Pfizer and Moderna announced they were developing a combination injection utilizing mRNA coding for the BA4/BA5 Omicron subvariant and new mRNA coding for antigens contained in the influenza virus.[i] Because the COVID-19 component is under Emergency Use Authorization, has failed in animal studies and no human trials have been reported, that component should be off the table from the start. A recent paper from Chemaitelly and colleagues demonstrated in the Omicron era, COVID-19 boosters had unacceptably low protection against acquiring the infection and no valid study has ever demonstrated reductions in hospitalizations and deaths.[ii] To make...